Use of Casirivimab and Imdevimab for the Treatment of COVID-19

Division

North Florida

Hospital

Ocala Regional Medical Center

Document Type

Case Report

Publication Date

8-8-2022

Keywords

case report, casirivimab, casirivimab and imdevimab, covid-19, imdevimab, monoclonal antibody treatment for covid-19, regen-cov

Disciplines

Emergency Medicine | Therapeutics | Virus Diseases

Abstract

The authors present three cases of unvaccinated coronavirus disease 2019 (COVID-19) patients who exhibited symptoms of fever, sore throat, nausea, diarrhea, congestion, and headache. Although they refused COVID-19 vaccination, they presented for the casirivimab and imdevimab monoclonal antibody cocktail, which resulted in the resolution of all symptoms. The authors describe the mechanisms and importance of monoclonal antibody treatment for high-risk and unvaccinated patients infected with SARS-CoV-2.

Publisher or Conference

Cureus

Link to Full Text

Share

COinS